Increased APOBEC3B Predicts Worse Outcomes in Lung Cancer: A Comprehensive Retrospective Study
Open Access
- 1 January 2016
- journal article
- Published by Ivyspring International Publisher in Journal of Cancer
- Vol. 7 (6) , 618-625
Abstract
Lung cancer ranks as the most common and lethal malignancy in America and worldwide. APOBEC3B is a newly identified DNA cytosine deaminase, which is supposed to function as a major source of DNA mutation in many different tumors. In this study, we combine the data of online databases and two hundred and twenty-one primary non-small-cell lung carcinoma (NSCLC) specimens from Sun Yat-sen University Cancer Center to investigate, for the first time, the clinical role of APOBEC3B in lung cancer. We found that the APOBEC3 expression was commonly elevated in NSCLC tissues and overexpression of APOBEC3B was correlated with unfavorable prognosis of the patients with NSCLC. Furthermore, APOBEC3B expression was associated with nodal status, TNM staging and adjuvant chemotherapy of the patients with NSCLC. Further research is warranted.Keywords
This publication has 22 references indexed in Scilit:
- The Global Burden of Cancer 2013JAMA Oncology, 2015
- APOBEC Enzymes: Mutagenic Fuel for Cancer Evolution and HeterogeneityCancer Discovery, 2015
- The roles of APOBEC3B in gastric cancer.2015
- Clonal status of actionable driver events and the timing of mutational processes in cancer evolutionScience Translational Medicine, 2015
- Lung cancer diagnosis: when speed wins the dayThe Lancet Respiratory Medicine, 2015
- APOBEC3Bexpression in breast cancer reflects cellular proliferation, while a deletion polymorphism is associated with immune activationProceedings of the National Academy of Sciences, 2015
- High Expression of Zinc-Binding Protein-89 Predicts Decreased Survival in Esophageal Squamous Cell CancerThe Annals of Thoracic Surgery, 2014
- The inhibition of hepatitis B virus by APOBEC cytidine deaminasesJournal of Viral Hepatitis, 2013
- APOBEC3B is an enzymatic source of mutation in breast cancerNature, 2013
- AID/APOBEC cytosine deaminase induces genome-wide kataegisBiology Direct, 2012